Derecho al acceso a tratamientos y medicamentos experimentales, caso Estados Unidos-Colombia: críticas a su traslación al ordenamiento interno.

This research article analyzes the incorporation of the right to access to experimental treatments in the United States of America and Colombia. It also examines its case-law insertion, essential elements, and the regulations that each country has established for the provision of these unconventional procedures and drugs. Subsequently, it makes a series of criticisms over how the Constitutional Court has migrated or translated this right from US case law and legislation to the Colombian health care system. Therefore, this paper intends to carry out a comparative analysis of both health care systems from the perspective of the role of both the State and health actors (manufacturers, insurers, patients) in accessing experimental drugs and procedures. [ABSTRACT FROM AUTHOR]